These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38536449)

  • 21. Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies.
    Anderson N; De Laat M; Benton S; von Dadelszen P; McCowan L
    Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):89-95. PubMed ID: 29851029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The predictive value of plasma fibronectin concentration on fetal growth retardation and preeclampsia at earlier stage of the third trimester].
    Xiong G; Wang Z; Yu Q
    Zhonghua Fu Chan Ke Za Zhi; 2001 Dec; 36(12):734-7. PubMed ID: 16136894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Causes and Results of Fetal Growth in Utero Caused by Genetic Factors Detected by Ultrasound.
    Yu M; Liu Y; Wang L
    Contrast Media Mol Imaging; 2022; 2022():3703132. PubMed ID: 36105440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of angiogenic markers in pregnancy with fetal growth restriction.
    Palmrich P; Kalafat E; Pateisky P; Schirwani-Hartl N; Haberl C; Herrmann C; Khalil A; Binder J
    Ultrasound Obstet Gynecol; 2024 May; 63(5):619-626. PubMed ID: 37774098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definitions matter: detection rates and perinatal outcome for infants classified prenatally as having late fetal growth restriction using SMFM biometric vs ISUOG/Delphi consensus criteria.
    Schreiber V; Hurst C; da Silva Costa F; Stoke R; Turner J; Kumar S
    Ultrasound Obstet Gynecol; 2023 Mar; 61(3):377-385. PubMed ID: 35866888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-Free DNA (cfDNA) Fetal Fraction in Early- and Late-Onset Fetal Growth Restriction.
    Morano D; Rossi S; Lapucci C; Pittalis MC; Farina A
    Mol Diagn Ther; 2018 Oct; 22(5):613-619. PubMed ID: 30056492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of late-onset fetal growth restriction: pragmatic approach.
    Peasley R; Rangel LAA; Casagrandi D; Donadono V; Willinger M; Conti G; Seminara Y; Marlow N; David AL; Attilakos G; Pandya P; Zaikin A; Peebles D; Napolitano R
    Ultrasound Obstet Gynecol; 2023 Jul; 62(1):106-114. PubMed ID: 36864542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic immune-inflammation index changes predict outcome in stage III non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
    Huang T; Zhang H; Zhao Y; Li Y; Wang G; Zhang Y; Guo D; Ji S; Sun Z
    Future Oncol; 2021 Jun; 17(17):2141-2149. PubMed ID: 33635094
    [No Abstract]   [Full Text] [Related]  

  • 29. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
    J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk stratification for early-onset fetal growth restriction in women with abnormal serum biomarkers: a retrospective cohort study.
    Ormesher L; Warrander L; Liu Y; Thomas S; Simcox L; Smith GCS; Myers JE; Johnstone ED
    Sci Rep; 2020 Dec; 10(1):22259. PubMed ID: 33335122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolvin D1 level during different trimesters of pregnancy for predicting the risk of fetal growth retardation in elderly pregnancy.
    Han Y; Wang D; Cai S; Zhang L; Xue J
    Scand J Clin Lab Invest; 2024 May; 84(3):154-159. PubMed ID: 38639268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathologic placental lesions in early and late fetal growth restriction.
    Spinillo A; Gardella B; Adamo L; Muscettola G; Fiandrino G; Cesari S
    Acta Obstet Gynecol Scand; 2019 Dec; 98(12):1585-1594. PubMed ID: 31370094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive prediction of fetal growth restriction by whole-genome promoter profiling of maternal plasma DNA: a nested case-control study.
    Xu C; Guo Z; Zhang J; Lu Q; Tian Q; Liu S; Li K; Wang K; Tao Z; Li C; Lv Z; Zhang Z; Yang X; Yang F
    BJOG; 2021 Jan; 128(2):458-466. PubMed ID: 32364311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of Fetal Growth Restriction by Analyzing the Messenger RNAs of Angiogenic Factor in the Plasma of Pregnant Women.
    Takenaka S; Ventura W; Sterrantino AF; Kawashima A; Koide K; Hori K; Farina A; Sekizawa A
    Reprod Sci; 2015 Jun; 22(6):743-9. PubMed ID: 25491486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal epicardial fat thickness in fetal growth restriction; effects on fetal heart function and relationship with the severity of disease.
    Yakut K; Öcal DF; Sanhal Yaşar C; Halıcı Öztürk F; Şanlı C; Çelen Ş
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6946-6952. PubMed ID: 34058950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of first-trimester NLR (neutrophil to lymphocyte ratio), systemic immune-inflammation index (SII), and, systemic immune-response index (SIRI) in the prediction of composite adverse outcomes in pregnant women with systemic lupus erythematosus.
    Sahin R; Tanacan A; Serbetci H; Agaoglu Z; Karagoz B; Haksever M; Kara O; Şahin D
    J Reprod Immunol; 2023 Aug; 158():103978. PubMed ID: 37329867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Predictive Model at 11
    Chang Y; Chen X; Cui HY; Li X; Xu YL
    Reprod Sci; 2017 May; 24(5):783-789. PubMed ID: 27678097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic Inflammation Response Index and Systemic Immune-inflammation Index for Prediction of Pregnancy Loss: a Case-control Study.
    Agaoglu Z; Tanacan A; Ipek G; Peker A; Ozturk Agaoglu M; Sahin D
    Reprod Sci; 2024 Jun; 31(6):1565-1572. PubMed ID: 38438777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study.
    Simón E; Herraiz I; Villalaín C; Gómez-Arriaga PI; Quezada MS; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2020 Apr; 20():44-49. PubMed ID: 32172169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.